TFF2 and endometriosis: A comprehensive review, published in 2016, of published endometrial biomarkers of endometriosis involving 2729 participants concluded that only “17βHSD2, IL-1R2, caldesmon (a binding protein capable of regulating actomyosin contraction), and a number of neural markers (VIP, CGRP, SP, NPY and combination of VIP, PGP 9.5 and SP) showed promising evidence of diagnostic accuracy, but there was insufficient or poor quality evidence for any clinical recommendations.” [26].